ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Rat Liver Allo-Graft Rejection Promotes Anti-Cancer Immunity: A Model of Transplantation for Hepatocellular Carcinoma

S. Lacotte, G. Oldani, L. Rubbia-Brandt, F. Slits, L. Orci, P. Morel, G. Mentha, C. Toso

Surgery, University Geneva Hospital, Geneva, Switzerland
Pathology, University Geneva Hospital, Geneva, Switzerland

Meeting: 2013 American Transplant Congress

Abstract number: B884

Background: Liver transplantation for hepatocellular carcinoma (HCC) results in a specific condition where the immune response is directed both against allogeneic and cancer antigens. This study assessed the level of anti-cancer immunity during allogeneic rejection after rat liver transplantation.

Methods: Dark Agouti-to-Lewis (allogeneic) and Lewis-to-Lewis (syngeneic) rat liver transplantations were performed. The occurrence of a rejection was assessed (survival, histology, liver function tests and mixed lymphocyte reaction). The phenotype, the level of activation and the anti-cancer cytotoxic activity of mononuclear, monocyte/macrophage and NK cells were tested in the peripheral blood, the liver and the spleen.

Results: Allogeneic rats experienced rejection as testified by shorter survivals (13 vs. >60 days in syngeneic rats, p<0.01), the presence of rejection on histology (Banff 8) and increased liver function tests (p<0.01). Rejection was donor specific as shown by the increased IFNΓ secretion by recipient peripheral blood mononuclear cells (day 10) after stimulation by donor splenocytes (410 pg/ml). At time of rejection, blood cells demonstrated increased anti-cancer cell cytotoxicity (25.2 vs. 14.7% in syngeneic recipients, p<0.005). This activity was related to increased blood NK cell frequencies (10.79% vs 4.9%, p<0.05) and higher blood monocyte/macrophage activation levels (p<0.01). Similarly in the liver, the number of liver mononuclear cells was increased (16.106 vs. 5.35.106 cells/liver, p<0.01), as were liver NK cell-specific cytotoxicity (58.8% vs 32% respectively, p<0.005) and liver monocyte/macrophage activation levels (p<0.01). The phenotype and the anti-cancer function of spleen cells were not altered.

Conclusion: Liver graft rejection is associated to increased peripheral and liver cytotoxicity against cancer cells. This observation supports the use of milder immunosuppression after transplantation for HCC with the idea to improve post-transplant immune clearance of HCC cells.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Lacotte S, Oldani G, Rubbia-Brandt L, Slits F, Orci L, Morel P, Mentha G, Toso C. Rat Liver Allo-Graft Rejection Promotes Anti-Cancer Immunity: A Model of Transplantation for Hepatocellular Carcinoma [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/rat-liver-allo-graft-rejection-promotes-anti-cancer-immunity-a-model-of-transplantation-for-hepatocellular-carcinoma/. Accessed May 17, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences